Quantification of Macular Carotenoids Using Autofluorescence Imaging in Patients With Photosensitive Migraine and Benign Essential Blepharospasm | External Eye Disease | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.234.102. Please contact the publisher to request reinstatement.
1.
Headache Classification Subcommittee of the International Headache Society.  The International Classification of Headache Disorders: 2nd edition.  Cephalalgia. 2004;24:(suppl 1)  9-16014979299PubMedGoogle ScholarCrossref
2.
Hallett M, Evinger C, Jankovic J, Stacy M.BEBRF International Workshop.  Update on blepharospasm: report from the BEBRF International Workshop.  Neurology. 2008;71(16):1275-128218852443PubMedGoogle ScholarCrossref
3.
Adams WH, Digre KB, Patel BC, Anderson RL, Warner JE, Katz BJ. The evaluation of light sensitivity in benign essential blepharospasm.  Am J Ophthalmol. 2006;142(1):82-8716815254PubMedGoogle ScholarCrossref
4.
Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ. The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders.  Vision Res. 2010;50(7):716-72819854211PubMedGoogle ScholarCrossref
5.
Blackburn MK, Lamb RD, Digre KB,  et al.  FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm.  Ophthalmology. 2009;116(5):997-100119410958PubMedGoogle ScholarCrossref
6.
Sharifzadeh M, Bernstein PS, Gellermann W. Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions.  J Opt Soc Am A Opt Image Sci Vis. 2006;23(10):2373-238716985523PubMedGoogle ScholarCrossref
Research Letter
Feb 2012

Quantification of Macular Carotenoids Using Autofluorescence Imaging in Patients With Photosensitive Migraine and Benign Essential Blepharospasm

Author Affiliations

Author Affiliations: John A. Moran Eye Center, Department of Ophthalmology and Visual Sciences (Mr Frandsen and Drs Digre, Bernstein, Warner, and Katz) and Department of Neurology (Drs Digre, Warner, and Katz), Health Sciences Center, and Department of Physics and Astronomy (Drs Sharifzadeh and Gellerman), University of Utah, Salt Lake City; and University of Puerto Rico School of Medicine, San Juan, Puerto Rico (Ms Llop).

Arch Ophthalmol. 2012;130(2):259-260. doi:10.1001/archopthalmol.2011.1372

Photophobia describes light sensitivity or abnormal intolerance of light. Patients with photophobia avoid light because of pain or discomfort. Photophobia may be reported by individuals with conditions not necessarily affecting the eye. Two such conditions are migraine and benign essential blepharospasm.1,2 We have previously demonstrated that patients with migraine or blepharospasm are more light sensitive than age-matched control subjects.3

The pathophysiology of light sensitivity is unknown. We suspected that patients with photophobia might have abnormally low levels of the xanthophyll carotenoids lutein and zeaxanthin in their retinas. These carotenoids filter out phototoxic short-wavelength visible light and function as antioxidants.4 We have previously demonstrated that a rose-colored spectacle tint, FL-41, can ameliorate symptoms of light sensitivity in patients with blepharospasm.5 Because of the similarity between the transmission spectra of FL-41 and carotenoids, we hypothesized that photophobic individuals may have reduced levels of carotenoids in their maculae.

×